Literature summary extracted from

Brugts, J.J.; Danser, A.H.; de Maat, M.P.; den Uil, C.A.; Boersma, E.; Ferrari, R.; Simoons, M.L.
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy (2008), Curr. Opin. Cardiol., 23, 296-301.

Application

EC Number	Application	Comment	Organism
3.4.15.1	medicine	ACE is associated with stable coronary artery disease	Homo sapiens

Inhibitors

EC Number	Inhibitors	Comment	Organism	Structure
3.4.15.1	benazepril	-	Homo sapiens
3.4.15.1	captopril	-	Homo sapiens
3.4.15.1	lisinopril	-	Homo sapiens

Natural Substrates/ Products (Substrates)

EC Number	Natural Substrates	Organism	Comment (Nat. Sub.)	Natural Products	Comment (Nat. Pro.)	Rev.	Reac.
3.4.15.1	angiotensin I + H2O	Homo sapiens	-	angiotensin II + L-His-L-Leu	-	?

Organism

EC Number	Organism	UniProt	Comment	Textmining
3.4.15.1	Homo sapiens	-	-	-

Substrates and Products (Substrate)

EC Number	Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
3.4.15.1	angiotensin I + H2O	-	Homo sapiens	angiotensin II + L-His-L-Leu	-	?

Synonyms

EC Number	Synonyms	Comment	Organism
3.4.15.1	ACE	-	Homo sapiens
3.4.15.1	angiotensin-converting enzyme	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)